Lords Mark Industries Limited has submitted an application to the National Stock Exchange of India Limited (NSE) seeking listing and trading approval for its existing issued, subscribed, and fully paid-up equity shares. The disclosure, made on July 24, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, signals the company’s intent to expand its market presence beyond its current listing on BSE Limited. This dual-listing strategy aims to provide a nationwide trading platform, thereby enhancing liquidity and improving accessibility for a broader investor base.

The application is part of a strategic effort to increase the visibility of the company’s equity shares, which are identified by scrip code 501261 on the Bombay Stock Exchange. By securing a listing on the NSE, Lords Mark Industries intends to tap into a larger pool of investors and improve the tradability of its shares. The move is particularly relevant for a company operating in the specialized medical device sector, where broader market access can facilitate better price discovery and capital efficiency.

Regulatory Framework and Approvals

The submission was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified the Manager – Listing Department at BSE Limited regarding this development. The proposed listing on the NSE remains subject to the receipt of necessary approvals, permissions, and observations from the National Stock Exchange of India Limited and other applicable regulatory authorities. Lords Mark Industries has committed to keeping the stock exchanges informed of any further material developments, including the final receipt of listing and trading approval.

Corporate Profile and Brand Portfolio

Lords Mark Industries Limited, formerly known as Lords Mark Industries Limited and Kratos Energy & Infrastructure Limited, operates through distinct brand verticals including LordsMed, Lord's Renal, and Lord's Surgical. These brands reflect the company’s focus on medical devices and healthcare solutions. The corporate office is located in Thane West, Maharashtra, while the registered office is situated in Borivali (E), Mumbai. The disclosure was signed by Mr. Sachidanand Hariram Upadhyay, Managing Director, who holds DIN No. 01631728.

What the Numbers Show

While this filing does not disclose specific financial metrics such as revenue or profit figures, the strategic decision to pursue a dual listing highlights management’s confidence in the company’s operational stability and growth trajectory. The absence of financial data in this specific regulatory intimation means that investors should refer to previous quarterly results or annual reports for performance indicators. However, the procedural step of applying for NSE listing often precedes increased institutional interest, as many large-cap funds prefer trading on the NSE due to its higher liquidity and electronic trading infrastructure. For shareholders, this development represents a potential improvement in share liquidity and ease of trade execution.

The company will continue to update stakeholders on the progress of the application. Until formal approval is granted by the NSE, the shares will continue to trade exclusively on the BSE. Investors are advised to monitor official communications from the company for updates on the listing timeline and any associated costs or requirements for demat account holders.

Lord's Mark Industries Limited has secured a significant order from the Chhattisgarh State Renewable Energy Development Agency (CREDA) to supply and install Solar Home Lighting Systems across the state. The company's Lighting Division achieved the lowest bidder (L1) status and formally accepted the Letter of Offer from the state government agency. This project expands the company's market footprint in the renewable energy and lighting infrastructure sector.

The contract entails the supply, installation, and commissioning of Solar Home Lighting Systems with a minimum capacity of 300 Wp. The agreement includes a 5-year Comprehensive Maintenance Contract (CMC) and an onsite unconditional warranty. The execution will follow standard project timelines stipulated by CREDA once the agreement process is finalized.

Financial and Contractual Details

The order details were disclosed in a regulatory filing submitted to BSE Limited. The breakdown of the approved L1 unit rate is provided in the table below.

Strategic Implications

Management highlighted that securing the L1 status underscores the company's competitive cost efficiencies, robust supply chain, and advanced engineering capabilities in the clean energy space. The project covers the entire state of Chhattisgarh, marking a strategic expansion for the Lighting and Renewable Energy Division. The company confirmed that it has accepted the offer and is currently completing the formal contract agreements within the stipulated timelines.